IMR Press / EJGO / Special Issues / 1622454038386

Rare Gynecological Malignancies

Submission deadline: 31 December 2021
Special Issue Editors
Aristotelis Bamias, MD
2nd Propaedeutic Dept of Internal Medicine, National & Kapodistrian University of Athens, ATTIKON University Hospital, Athens, Greece
Interests: Urogenital and Gynaecological Cancer
Michalis Liontos, MD, PhD
Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Interests: ovarian cancer; gynecological oncology; clinical research; cancer biology; biomarkers
Special Issue and Collections in IMR journals
Special Issue Information

Dear Colleagues,
Gynecological cancers are characterized by rare entities more frequently than any other system. For example, all epithelial and non-epithelial neoplasms of the ovary are designated as rare cancers, with the exception of High Grade Serous carcinomas. Analogously, rare carcinomas are encountered among uterine and cervical carcinomas. The management of these neoplasms is affected by their rarity. Clinical trials investigating therapeutic modalities for these cances are seldom and frequently clinical decisions are based on retrospective data, small non-randomized trials or experts‘ opinion. However, data arising from the molecular analysis of these tumours have offered novel insights in their pathogenesis and new therapeutic opportunities. In addition, many european countries organize centres of excellence in order to provide optimal care for the patients with rare gynecological malignancies. Under this perspective, the scope of this special issue is to comprehensively present novel data regarding rare gynecological cancers and to disseminate experts‘ opinions that could assist in the appropriate managemen of these patients.

Prof. Aristotelis Bamias and Dr. Michalis Liontos

Guest Editors

Keywords
Rare cancers
Ovarian cancer
Cervical cancer
Endometrial cancer
Biomarkers
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top